全文获取类型
收费全文 | 742835篇 |
免费 | 52081篇 |
国内免费 | 1363篇 |
专业分类
耳鼻咽喉 | 9545篇 |
儿科学 | 24420篇 |
妇产科学 | 18426篇 |
基础医学 | 116334篇 |
口腔科学 | 20240篇 |
临床医学 | 67194篇 |
内科学 | 143120篇 |
皮肤病学 | 17111篇 |
神经病学 | 52991篇 |
特种医学 | 26873篇 |
外国民族医学 | 106篇 |
外科学 | 109328篇 |
综合类 | 14900篇 |
现状与发展 | 2篇 |
一般理论 | 169篇 |
预防医学 | 54037篇 |
眼科学 | 16935篇 |
药学 | 56581篇 |
3篇 | |
中国医学 | 2433篇 |
肿瘤学 | 45531篇 |
出版年
2021年 | 6045篇 |
2019年 | 6082篇 |
2018年 | 8934篇 |
2017年 | 6889篇 |
2016年 | 7582篇 |
2015年 | 8471篇 |
2014年 | 11285篇 |
2013年 | 16948篇 |
2012年 | 23099篇 |
2011年 | 24061篇 |
2010年 | 14007篇 |
2009年 | 13009篇 |
2008年 | 22307篇 |
2007年 | 23867篇 |
2006年 | 24120篇 |
2005年 | 22806篇 |
2004年 | 22360篇 |
2003年 | 21085篇 |
2002年 | 20469篇 |
2001年 | 37311篇 |
2000年 | 37922篇 |
1999年 | 31229篇 |
1998年 | 8101篇 |
1997年 | 6836篇 |
1996年 | 7134篇 |
1995年 | 6776篇 |
1994年 | 6227篇 |
1992年 | 23446篇 |
1991年 | 23350篇 |
1990年 | 22757篇 |
1989年 | 22479篇 |
1988年 | 20396篇 |
1987年 | 19788篇 |
1986年 | 18784篇 |
1985年 | 17603篇 |
1984年 | 12908篇 |
1983年 | 10914篇 |
1982年 | 6035篇 |
1979年 | 11675篇 |
1978年 | 8221篇 |
1977年 | 6918篇 |
1976年 | 6678篇 |
1975年 | 7348篇 |
1974年 | 8614篇 |
1973年 | 8254篇 |
1972年 | 7766篇 |
1971年 | 7238篇 |
1970年 | 6979篇 |
1969年 | 6436篇 |
1968年 | 5893篇 |
排序方式: 共有10000条查询结果,搜索用时 578 毫秒
51.
52.
53.
54.
55.
56.
57.
58.
Qianlai Luo Jonathan N. Hofmann Ruth M. Pfeiffer Cari M. Kitahara Minkyo Song Meredith S. Shiels 《International journal of cancer. Journal international du cancer》2023,153(1):64-72
In the United States, renal cell carcinoma (RCC) incidence and the prevalence of obesity, an established risk factor for RCC, have been increasing for several decades. RCC is more common among older individuals. We sought to quantify the contribution of excess adiposity to the rising incidence of RCC among individuals 60 years or older. National Institutes of Health-American Association of Retired Persons Diet and Health Study data (n = 453 859 participants, enrolled in 1995-1996, age at enrollment 50-71 years) were used to estimate multivariable-adjusted hazard ratios (HRs) for RCC across body mass index categories and HRs associated with smoking. Population attributable fractions (PAFs) were calculated using estimated HRs and annual overweight/obesity prevalence from the National Health Interview Survey (1985-2008). PAF estimates were combined with RCC incidence from Surveillance, Epidemiology and End Results-13 to calculate annual percent changes in RCC incidence attributable (and unrelated) to overweight/obesity. We found that between 1995 and 2018, among individuals aged 60 years and older, PAF for overweight/obesity increased from 18% to 29% for all RCCs. In comparison, the PAF for smoking declined from 12% to 9%. RCC incidence increased 1.8% per year (95% confidence interval [CI] 1.5%-2.1%) overall, while RCC incidence attributable to overweight/obesity increased 3.8% per year (95%CI 3.5%-4.2%) and RCC incidence unrelated to overweight/obesity increased 1.2% per year (95% CI 0.9%-1.4%). In conclusion, overweight/obesity appears to have contributed importantly to the rising incidence of RCC in the United States since the mid-1990s. Public health interventions focused on reducing overweight and obesity could help substantially in curbing this trend. 相似文献
59.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献